Ptc Therapeutics PTCT
NASDAQ PTCT
$65.00 -0.95 (-1.44%)
As of: Sep 29, 2026 · 3:59 PM EDT

Ptc Therapeutics (PTCT) Research & Development (2012 - 2026)

Updated

Ptc Therapeutics' Research & Development was $99.15 million in Q2 2026, down 12.2% from $112.99 million a year earlier and down 1.7% from the prior quarter.

Analysis

Ptc Therapeutics (PTCT) Research & Development (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ptc Therapeutics' Research & Development was $433.31 million through Jun 30, 2026, down 14.7% year-over-year; for FY2025, it was $455.25 million, down 14.8% from FY2024.

  • Research & Development shows a five-year compound annual growth rate of -1.0% (FY2020 to FY2025).
  • In earlier years, Research & Development was $534.48 million in FY2024 (-19.8%), $666.56 million in FY2023 (+2.3%), $651.5 million in FY2022 (+20.5%) and $540.68 million in FY2021 (+13.2%).
  • The Q2 2026 figure marks the lowest quarterly Research & Development since Q3 2020.
  • Compared with a year earlier, Research & Development was higher in two of the last eight quarters, with an average decline of 8.8%.
  • The best year-over-year quarter for Research & Development over five years was Q3 2021 (growth of 40.7%); the worst was Q1 2024 (a decline of 40.5%).
  • Per Business Quant data, PTCT's Research & Development in the three quarters before Q2 2026 was $100.87 million (Q1 2026), $133.13 million (Q4 2025) and $100.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Ptc Therapeutics 5.50 Bn -2.26 Bn 340.60 Mn 99.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 99.15 Mn
Mar 31, 2026 100.87 Mn
Dec 31, 2025 133.13 Mn
Sep 30, 2025 100.16 Mn
Jun 30, 2025 112.99 Mn
Mar 31, 2025 108.97 Mn
Dec 31, 2024 124.77 Mn
Sep 30, 2024 161.41 Mn
Jun 30, 2024 132.17 Mn
Mar 31, 2024 116.13 Mn
Dec 31, 2023 121.35 Mn
Sep 30, 2023 164.21 Mn
Jun 30, 2023 185.87 Mn
Mar 31, 2023 195.12 Mn
Dec 31, 2022 188.69 Mn
Sep 30, 2022 165.46 Mn
Jun 30, 2022 157.26 Mn
Mar 31, 2022 140.08 Mn
Dec 31, 2021 149.84 Mn
Sep 30, 2021 130.85 Mn
API Access

Ptc Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=PTCT&period=max&api_key=YOUR_API_KEY